Concepedia

Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial

Paolo Bossi, Andrea Alberti, Cristiana Bergamini, Carlo Resteghini, Laura D. Locati, Salvatore Alfieri, Stefano Cavalieri, Elena Colombo, Cristina Gurizzan, Luigi Lorini,

European Journal of Cancer · 2025 · 15 citations · 26 references

DOIFull text

Open access

Concepts

References

26

Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, 2012

Howard W. Rogers, Martin A. Weinstock, Steven R. Feldman et al. · JAMA Dermatology · 2015 · 1.8K citations · Full text

, , +17

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

Michael R. Migden, Nikhil I. Khushalani, Anne Lynn S. Chang et al. · The Lancet Oncology · 2020 · 480 citations · Full text

, , +13

Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin

E. Maubec, Peter Petrow, Isabelle Scheer-Senyarich et al. · Journal of Clinical Oncology · 2011 · 467 citations · Full text

, , +17

Antibody-Dependent Cellular Cytotoxicity Mediated by Cetuximab against Lung Cancer Cell Lines

Jun Kurai, Hiroki Chikumi, Kiyoshi Hashimoto et al. · Clinical Cancer Research · 2007 · 434 citations · Full text

, , +15

Antibody‐dependent cellular cytotoxicity of cetuximab against tumor cells with wild‐type or mutant epidermal growth factor receptor

Hideharu Kimura, Kazuko Sakai, Tokuzo Arao et al. · Cancer Science · 2007 · 279 citations · Full text

, , +16